OXIME DERIVATIVES AND PREPARATION THEREOF Russian patent published in 2011 - IPC C07D417/12 C07D417/14 C07D513/04 C07D213/75 C07D277/46 C07D285/08 C07D241/20 C07D403/06 C07D405/12 C07D251/32 A61K31/433 A61P3/04 A61P3/10 A61P9/10 

Abstract RU 2420525 C2

FIELD: medicine.

SUBSTANCE: in formula (I) , the ring A represents 6-members aryl or 5-6-members heteroaryl containing 1-2 heteroatoms selected from nitrogen and sulphur; Q means C3-8 cycloalkyl, 5-6-members heterocycle containing 1 heteroatom selected from oxygen, nitrogen or sulphur, C1-6 alkyl or C2-6 alkenyl; the ring T represents 5, 6, 9 or 10-members heteroaryl or 9-members heterocycle optionally additionally substituted by 1-3 heteroatoms independently selected from nitrogen or sulphur. The values of other substitutes are specified in the patent claim. Also, the invention refers to methods for preparing oxime derivatives of general formula (I), to pharmaceutical compositions containing the compound of the invention as an active ingredient and to applications of the compounds of the invention in preparing a drug.

EFFECT: compounds of the invention exhibit properties of a glucokinase activator.

33 cl, 1499 ex

Similar patents RU2420525C2

Title Year Author Number
CONDENSED HETEROCYCLIC COMPOUND 2009
  • Li Chang Seok
  • Li Tae Khee
  • Joon Sook Kiung
  • Choj Dzeung Soon
  • Dzang Iong Dzin
  • Kim Sung Vook
  • Chang Khie Kiung
  • Park Mi Dzeong
  • Kim Tae Khun
  • Akhn Joung Kha
  • Park Khee Dong
  • Park Khiun Dzung
  • Lim Dong Chul
  • Li Dzoo Joun
  • Li Sung Khak
  • Park Van Su
  • Okh Jeong Soo
RU2480473C2
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR 2007
  • Manli Pol U.
RU2481840C2
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS 2009
  • Ueta Kiitiro
  • Arakava Kendzi
  • Matsusita Jasuaki
RU2481106C2
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC 2005
  • Arimoto Khirokazu
  • Lu Tszjun'
  • Jamano Josinori
  • Jasukata Tatsuro
  • Josida Osamu
  • Ivaki Tsutomu
  • Josida Jutaka
  • Kato Issei
  • Morimoto Kendzi
  • Jasosima Kajo
RU2424248C2
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION 1997
  • Lum Robert T.
  • Blum Cheri Linn
  • Makman Richard
  • Vik Majkl M.
  • Skou Stiven R.
RU2220968C2
ARYL, HETEROARYL AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS 2018
  • Uajls, Dzhejson, Allan
  • Fadke, Avinash, S.
  • Deshpande, Milind
  • Agarval, Atul
  • Chen, Davej
  • Gadkhachanda, Venkat, Rao
  • Khashimoto, Akikhiro
  • Pejs, Godvin
  • Van, Tsyupin
  • Van, Syanchzhu
  • Berrish, Dzhoel, Charlz
  • Grinli, Uillyam
  • Istman, Kajl, Dzh.
RU2801278C2
NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS 2015
  • Doherty, James, J.
  • Quirk, Michael, C.
  • Martinez Botella, Gabriel
RU2764702C2
DERIVATIVES OF BENZAMIDE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1999
  • Braun Dirg Saterlend
  • Braun Dzhordzh Robert
RU2215736C2
FIVE-MEMBERED HETEROCYCLES AS INHIBITORS OF LEUKOCYTE ADHESION AND VLA-4 ANTAGONISTS 1997
  • Shtil'Ts Khans Ul'Rikh
  • Vener Fol'Kmar
  • Knolle Jokhen
  • Bartnik Ehkart
  • Khjul'S Kristof
RU2229296C2
HETEROCYCLIC COMPOUND, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2000
  • Taniguti Kiesi
  • Neja Masakhiro
  • Terasava Takesi
  • Jamazaki Khitosi
  • Sato Kentaro
  • Khosoj Kumi
  • Tomisima Jasujo
  • Esida Noriko
  • Imamura Esimasa
  • Takasugi Khisasi
  • Setoi Khirojuki
RU2221792C2

RU 2 420 525 C2

Authors

Sugavara Kazutosi

Matsudaira Tetsudzi

Sugama Khirosi

Navano Masao

Okhasi Rikija

Dates

2011-06-10Published

2006-07-10Filed